After a baby became the world's first CRISPR gene editing therapy patient, CHOP wants to expand treatment to others

One year after receiving CRISPR gene editing therapy at CHOP, a Delaware County baby is thriving, and doctors want to expand ...

'Off the shelf' immunotherapy could get a lift from gene-edited natural killer cells

Since scientists first discovered that human immune cells could be modified to become cancer-fighting agents, they've been trying to engineer a cell that's effective against solid tumors, which ...
PharmiWeb

Gene Synthesis Market Comprehensive Industry Analysis, Trends, and Future Outlook

The Gene Synthesis Market has emerged as one of the most transformative segments within modern biotechnology, driven by rapid ...
Frontiers

Gene editing in vaccine development against vectors and vector-borne diseases (VBDs)

Vector-borne diseases (VBDs) represent a critical challenge in infectious disease control due to their complex transmission dynamics, diverse vector ...

Therna Biosciences Appoints Biotech Veteran Devyn Smith, Ph.D., to Board of Directors and Expands Strategic and Scientific Advisory Leadership

"Devyn brings a rare combination of scientific depth, operational leadership, and strategic perspective," said Nazli Azimi, Ph.D., Chief Executive Officer of Therna. "His experience across genetic ...